Infants exclusively breastfed in the first 3 days of life had fewer food allergies at 1 year of age than those who also got ...

Omalizumab (Xolair) injections outperformed oral immunotherapy (OIT) in increasing tolerance among children with multi-food ...

Early dietary diversity in infants may reduce the risk of food allergies by promoting immune tolerance and gut microbiome ...

Omalizumab is superior to oral immunotherapy (OIT) for multifood allergy, and most patients include dietary consumption (DC) ...

The study of success eating food triggers after stopping Xolair is ongoing, so researchers are still collecting data for doctors to use making treatment plans with their patients. Parents interested ...

Omalizumab works by binding to the allergy-causing antibody called immunoglobulin E in the blood and preventing it from ...

Roche’s asthma drug Xolair appears to be safer and more effective than oral immunotherapy at treating adults and children ...

Pharvaris (PHVS) highlighted safety and efficacy data of deucrictibant, which is currently being evaluated in two pivotal Phase 3 studies, ...

A new study has revealed that the injectable asthma drug helped more than one-third of the kids to overcome their food ...

Immunoglobulin G hypogammaglobulinemia was found in 44.7% of patients with acute exacerbations of COPD receiving triple ...

More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...